Why 1 #copywriter’s trek through #PharmaAdvertising shows the #talentcrisis facing the industry. We review #AdNomad http://wp.me/P23AlC-v0

How a 600p #novel about #PharmaAdvertising reveals what’s wrong with #advertising today. We review #AdNomad http://wp.me/P23AlC-v0

Gilead pays $4.3B for CymaBay, primarily for liver disease med—Pharma showed up for the big game — CSL’s ‘big’ post-heart attack drug fails in Phase III trial--http://bit.ly/w28kSd #gileadsciences #mergersandacquisitions #liverdisease #heartattack #clinicaltrials #superbowl #pharmaadvertising #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma